4
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001209191-23-021260
Options or other derivatives
- Chief Financial Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Calabrese Salvatore · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-23 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +50,000 | 50,000 | D |
| 2023-03-23 | Grant or award : show line 2 in the form Restricted Stock Units | +25,000 | 25,000 | D |
Loading xslF345X04/doc4.xml…